person · Reporting owner

Gajendra Sanjay

Disclosed activity across 1 company

Tapewire entity: 21503
SEC CIK: 0001998179

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Astera Labs, Inc.ALAB · Entity 1853	Director · President and COO	August 17, 2026	August 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Astera Labs, Inc.

Report date August 17, 2026 · Filed August 19, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,119,038	Ending reported balance After 2026-08-17 transaction · row 18 18 source rows · reconciled sequence Row 1 · 2026-08-17 · Sale · Disposed 578 · Balance 1,209,090 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-08-17 · Sale · Disposed 1,049 · Balance 1,208,041 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-08-17 · Sale · Disposed 1,984 · Balance 1,206,057 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-08-17 · Sale · Disposed 1,057 · Balance 1,205,000 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-08-17 · Sale · Disposed 3,500 · Balance 1,201,500 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 6 · 2026-08-17 · Sale · Disposed 2,525 · Balance 1,198,975 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 7 · 2026-08-17 · Sale · Disposed 17,373 · Balance 1,181,602 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 8 · 2026-08-17 · Sale · Disposed 3,713 · Balance 1,177,889 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 9 · 2026-08-17 · Sale · Disposed 5,449 · Balance 1,172,440 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 10 · 2026-08-17 · Sale · Disposed 1,610 · Balance 1,170,830 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 11 · 2026-08-17 · Sale · Disposed 2,616 · Balance 1,168,214 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 12 · 2026-08-17 · Sale · Disposed 6,484 · Balance 1,161,730 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 13 · 2026-08-17 · Sale · Disposed 7,992 · Balance 1,153,738 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 14 · 2026-08-17 · Sale · Disposed 10,438 · Balance 1,143,300 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 15 · 2026-08-17 · Sale · Disposed 2,946 · Balance 1,140,354 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 16 · 2026-08-17 · Sale · Disposed 1,782 · Balance 1,138,572 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 17 · 2026-08-17 · Sale · Disposed 6,926 · Balance 1,131,646 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 18 · 2026-08-17 · Sale · Disposed 12,608 · Balance 1,119,038 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Common StockSEC Table I · non-derivative	IndirectBy Trust 1	5,290,402	Reported balance Holding disclosure · report date 2026-08-17 · row 19 Holding and transaction disclosures are not merged. 1 source row Row 19 · Balance 5,290,402 F20: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy Trust 2	615,000	Reported balance Holding disclosure · report date 2026-08-17 · row 20 Holding and transaction disclosures are not merged. 1 source row Row 20 · Balance 615,000 F21: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy Trust 3	615,000	Reported balance Holding disclosure · report date 2026-08-17 · row 21 Holding and transaction disclosures are not merged. 1 source row Row 21 · Balance 615,000 F22: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F20: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F21: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F22: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	914	$196.94	$180,001.33	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 20 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 682,072 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $196.4500 to $197.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F17 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	5,677	$195.74	$1,111,211.44	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 19 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 682,986 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F18 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $195.4500 to $196.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F17 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,104	$194.91	$605,004.68	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 18 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 688,663 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $194.4500 to $195.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F17 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,288	$193.95	$443,767.21	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 17 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 691,767 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $193.4500 to $194.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F17 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	945	$193.01	$182,397.95	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 16 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 694,055 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.4400 to $193.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F17 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,415	$213.49	$729,068.35	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 15 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,664,213 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,163	$205.94	$239,507.17	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 14 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,667,628 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F16 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $205.5000 to $206.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,915	$205.26	$598,340.48	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 13 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,668,791 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F15 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.5000 to $205.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,702	$203.89	$550,919.16	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 12 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,671,706 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F14 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.5000 to $204.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,208	$202.89	$1,665,353.13	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 11 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,674,408 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F13 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.5000 to $203.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,477	$202.09	$1,713,116.08	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 10 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,682,616 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.4600 to $202.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	9,016	$200.86	$1,810,965.48	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 9 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,691,093 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.4500 to $201.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	10,913	$199.90	$2,181,495.60	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 8 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,700,109 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.4500 to $200.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	43,016	$198.82	$8,552,595.98	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 7 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,711,022 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $198.4500 to $199.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	45,536	$198.21	$9,025,522.08	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 6 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,754,038 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $197.4500 to $198.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	4,568	$196.94	$899,613.70	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,799,574 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $196.4500 to $197.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,387	$195.74	$5,556,451.51	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,804,142 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $195.4500 to $196.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	15,523	$194.91	$3,025,606.56	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,832,529 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $194.4500 to $195.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	11,436	$193.95	$2,218,059.09	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,848,052 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $193.4500 to $194.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 00:42 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	4,725	$193.01	$911,990.21	Disclosure SEC source: 0001998179-26-000011 · wk-form4_1778546529.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,859,488 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.4400 to $193.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	682	$213.49	$145,600.18	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 23 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 655,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	230	$205.94	$47,367.19	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 22 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 655,682 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $205.8400 to $206.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	586	$205.26	$120,284.82	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 21 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 655,912 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F18 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.6600 to $205.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	541	$203.89	$110,305.79	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 20 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 656,498 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.5000 to $204.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,640	$202.89	$332,745.50	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 19 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 657,039 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.5000 to $203.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,696	$202.09	$342,744.64	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 18 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 658,679 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.4600 to $202.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,804	$200.86	$362,353.60	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 17 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 660,375 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.4500 to $201.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,182	$199.90	$436,178.75	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 16 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 662,179 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.4500 to $200.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,603	$198.82	$1,710,479.43	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 15 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 664,361 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F17 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $198.4500 to $199.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	9,108	$198.21	$1,805,262.98	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 14 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 672,964 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F16 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $197.4500 to $198.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	913	$196.94	$179,804.76	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 13 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 682,072 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F15 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $196.4500 to $197.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	5,678	$195.74	$1,111,407.75	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 12 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 682,985 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F14 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $195.4500 to $196.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,104	$194.91	$605,004.36	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 11 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 688,663 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F13 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $194.4500 to $195.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,287	$193.95	$443,573.48	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 10 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 691,767 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $193.4500 to $194.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	946	$193.01	$182,590.96	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 9 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 694,054 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.4400 to $193.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	683	$213.49	$145,813.67	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 8 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 655,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	229	$205.94	$47,161.22	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 7 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 655,683 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $205.8400 to $206.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	586	$205.27	$120,285.35	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 6 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 655,912 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.6900 to $205.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	541	$203.89	$110,305.95	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 656,498 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.5000 to $204.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,640	$202.89	$332,746.16	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 657,039 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.5000 to $203.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,696	$202.09	$342,745.15	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 658,679 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.4600 to $202.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,804	$200.86	$362,353.97	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 660,375 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.4500 to $201.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 07, 2026 Filed May 12, 2026 01:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,182	$199.90	$436,178.96	Disclosure SEC source: 0001998179-26-000013 · wk-form4_1778549820.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 662,179 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.4500 to $200.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:52 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	9,185	$126.34	$1,160,432.90	Disclosure SEC source: 0001998179-26-000004 · wk-form4_1771552360.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,531,301 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:52 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	18,115	$124.66	$2,258,165.18	Disclosure SEC source: 0001998179-26-000004 · wk-form4_1771552360.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,540,486 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.3500 to $125.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:52 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,183	$123.93	$3,492,679.73	Disclosure SEC source: 0001998179-26-000004 · wk-form4_1771552360.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558,601 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.3300 to $124.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:52 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	33,647	$122.84	$4,133,345.53	Disclosure SEC source: 0001998179-26-000004 · wk-form4_1771552360.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,586,784 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.3200 to $123.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:52 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	5,841	$122.16	$713,522.54	Disclosure SEC source: 0001998179-26-000004 · wk-form4_1771552360.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,620,431 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.1000 to $122.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 06, 2026 Filed Feb 10, 2026 23:52 UTC	Astera Labs, Inc. ALAB · Entity 1853	GrantCommon Stock	26,522	$0.00	$0.00	Disclosure SEC source: 0001998179-26-000002 · wk-form4_1770767529.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,626,272 F1 · shares: These shares represent an award of restricted stock units ("RSUs") granted on February 6, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
December 02, 2025 Filed Dec 4, 2025 00:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	GiftCommon Stock	71,000	$0.00	$0.00	Disclosure SEC source: 0001998179-25-000008 · wk-form4_1764809143.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 5,864,213 F1 · kind: Represents a bona fide gift of shares to a non-affiliated entity. F2 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.